Search results for "severity"

showing 10 items of 1287 documents

Survival trends and predictors of mortality in severe pelvic trauma: estimates from the German Pelvic Trauma Registry Initiative.

2010

Abstract Study objective To determine longitudinal trends in mortality, and the contribution of specific injury characteristics and treatment modalities to the risk of a fatal outcome after severe and complex pelvic trauma. Methods We studied 5048 patients with pelvic ring fractures enrolled in the German Pelvic Trauma Registry Initiative between 1991 and 1993, 1998 and 2000, and 2004 and 2006. Complete datasets were available for 5014 cases, including 508 complex injuries, defined as unstable fractures with severe peri-pelvic soft tissue and organ laceration. Multivariable mixed-effects logistic regression analysis was employed to evaluate the impact of demographic, injury- and treatment-a…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAbdominal InjuriesFractures BoneYoung AdultFracture FixationLaparotomyGermanyFracture fixationEpidemiologymedicineHumansRegistriesYoung adultPelvic BonesSurvival analysisGeneral Environmental ScienceAgedbusiness.industryMultiple TraumaAccidents TrafficOdds ratioMiddle AgedVascular System InjuriesSurvival AnalysisConfidence intervalSurgeryEmergency medicineGeneral Earth and Planetary SciencesInjury Severity ScoreFemalebusinessEpidemiologic MethodsInjury
researchProduct

Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab.

2002

Abstract Background: Psoriatic skin lesions in patients with Crohn's disease or psoriatic arthritis have shown improvement during infliximab treatment. Objective: The purpose of our study was to systematically assess the effects of infliximab in patients with psoriatic skin lesions. Methods: Eight patients with severe psoriasis were enrolled in an open-label clinical trial. Patients received infliximab, 5 mg/kg, intravenously at weeks 0, 2, and 6. The Psoriasis Area and Severity Index (PASI) was used to monitor disease activity at weeks 0, 2, 4, 6, 8, 10, and 14. Week 10 was the end point of the treatment phase; week 14 was the follow-up end point. Pruritus was assessed on a scale of 0 to 3…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAcanthosisDermatologyGastroenterologySeverity of Illness IndexPsoriatic arthritisPsoriasis Area and Severity IndexInternal medicinePsoriasisBiopsymedicineHumansPsoriasisAdverse effectInfusions IntravenousChemotherapymedicine.diagnostic_testbusiness.industryTumor Necrosis Factor-alphaAntibodies MonoclonalMiddle Agedmedicine.diseaseInfliximabInfliximabSurgeryTreatment OutcomeFemaleDermatologic Agentsbusinessmedicine.drugJournal of the American Academy of Dermatology
researchProduct

Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure

2003

Abstract Background/Aims Except for bleeding complications, other serious adverse reactions of coumarin anticoagulants such as hepatotoxicity or skin necrosis are comparatively rare. Nonetheless, a small number of coumarin-induced (sub-) acute liver failures has been published. Methods A retrospective analysis was performed of patients treated for liver disease between 1992 and 2002 at our department to evaluate the incidence, clinical findings and histopathology of coumarin-induced hepatotoxicity. Results The retrospective analysis revealed eight cases of phenprocoumon-induced hepatotoxicity, including three cases of (sub-) acute liver failure which resulted in two orthotopic liver transpl…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentLiver transplantationSeverity of Illness IndexGastroenterologyPhenprocoumonLiver diseaseGermanyInternal medicinemedicineHumansAdverse effectRetrospective StudiesHepatitisLiver injuryHepatologybusiness.industryLiver cellAnticoagulantsLiver Failure AcuteMiddle Agedmedicine.diseaseSurgeryAcute DiseasePhenprocoumonFemaleChemical and Drug Induced Liver InjuryComplicationbusinessmedicine.drugJournal of Hepatology
researchProduct

Cognitive behavioral therapy for chronic insomnia inoccupationalhealth services: Analyses of outcomes upto24monthspost-treatment

2013

Abstract Objective Cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for persistent insomnia. The purpose of this study was to examine the effectiveness of and response patterns to CBT-I among daytime and shift workers with insomnia over a 24-month follow-up in occupational health services (OHS). Methods The participants were 59 media workers with chronic insomnia, of whom 69% were reached at 24-month follow-up. Sleep diaries and questionnaires over seven measurement points were used as outcomes. Trained OHS nurses led the CBT-I groups. The study design was a non-randomized group intervention. Results Self-perceived severity of insomnia, sleep-related dysfunctional…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentOccupational Health ServicesExperimental and Cognitive PsychologyDysfunctional familyCognitive behavioral therapy for insomniaAffect (psychology)Severity of Illness IndexOccupational safety and healthMedical RecordsShift workSleep Disorders Circadian RhythmSleep Initiation and Maintenance DisordersSurveys and Questionnairesmental disordersmedicineInsomniaHumansCognitive Behavioral TherapyCognitionta3141Middle Aged3. Good healthCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyPhysical therapyFemalemedicine.symptomPsychologyClinical psychologyFollow-Up StudiesBehaviour Research and Therapy
researchProduct

Life goals after brain injury in the light of the dual process approach: empirical evidence and implications for neuropsychological rehabilitation.

2011

Sequelae of acquired brain injury endanger the realisation of important life-goals. Discrepancies arise between the importance attached to a goal and the success in realising it. This study investigates goal discrepancies and their influence on patients' subjective well-being (SWB) in different rehabilitation stages. Life-goals, SWB and daily functioning were assessed in 130 neurological inpatients and 42 outpatients by self-report questionnaires. Both patient groups reported greater discrepancies between importance and success of life-goals than a normative sample of healthy controls. In multiple regression modelling, goal discrepancy predicted SWB in the inpatient sample even when control…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPoison controlPersonal SatisfactionSeverity of Illness IndexOccupational safety and healthArts and Humanities (miscellaneous)Injury preventionActivities of Daily LivingmedicineHumansSubjective well-beingPsychiatryAcquired brain injuryApplied PsychologyPsychiatric Status Rating ScalesRehabilitationRehabilitationNeuropsychologyHuman factors and ergonomicsMiddle Agedmedicine.diseaseNeuropsychology and Physiological PsychologyBrain InjuriesCase-Control StudiesFemaleSelf ReportPsychologyGoalsClinical psychologyNeuropsychological rehabilitation
researchProduct

Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

2012

PURPOSE: Fluoroquinolones are popular and widely used in primary care and hospital settings. Premarketing studies showed a favourable side-effect profile. However, significant morbidity and the need for liver transplantation for acute liver failure have been reported. We reviewed the available data on liver damage linked to fluoroquinolones. METHODS: A systematic search of case reports on the MEDLINE database encompassing the years 2000-2011 was carried out. Additional references were found by a manual search of the retrieved paper. We also describe three new cases of hepatotoxicity attributable to fluoroquinolones seen at our Unit. RESULTS: Thirty-five cases were retrieved from MEDLINE (51…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentTreatment outcomePrimary careLiver transplantationfluoroquinoloneSeverity of Illness IndexSeverity of illnessMedicineHumansPharmacology (medical)Liver damageIntensive care medicinePharmacologyHepatitisLiver injurySettore MED/12 - Gastroenterologiabusiness.industryLiver failureGeneral MedicineMiddle Agedmedicine.diseaseAnti-Bacterial AgentsTreatment OutcomeItalyliver damageSettore BIO/14 - FarmacologiaFemaleDILIChemical and Drug Induced Liver InjurybusinessFluoroquinolones
researchProduct

Vitamin D serum levels in multiorgan failure critically ill patients undergoing continuous renal replacement therapies

2020

Introduction Severe vitamin D deficiency in critically ill patients is linked to mortality. There are no scientific data regarding vitamin D status in critically ill patients undergoing continuous renal replacement therapies. Material and methods We aimed to measure vitamin D serum levels in critically ill patients with multi-organ failure undergoing continuous renal replacement therapies. Vitamin D serum measurements in 12-hour time intervals were performed in 20 patients undergoing continuous renal replacement therapies through continuous veno-venous haemodiafiltration (the study group). The results were then compared with the historical control group (20 patients without renal replacemen…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentcontinuous renal replacement therapyvitamin DCritical Care and Intensive Care MedicineSeverity of Illness IndexGastroenterologyvitamin D deficiencyAnesthesiologyInternal medicineIntensive caremedicineVitamin D and neurologyHumanscritical illnessRD78.3-87.3Renal replacement therapycritical illness.intensive careRC86-88.9Critically illbusiness.industryAcute kidney injuryMedical emergencies. Critical care. Intensive care. First aidGeneral MedicineMiddle AgedVitamin D Deficiencymedicine.diseaseMultiorgan failureAnesthesiology and Pain Medicineacute kidney injuryCase-Control StudiesCritical illnessbusinessAnaesthesiology Intensive Therapy
researchProduct

Severe herpes simplex virus type-I infections after dental procedures

2010

Background: Recurrences of herpes labialis (RHL) may be triggered by systemic factors, including stress, menses, and fever. Local stimuli, such as lip injury or sunlight exposure are also associated to RHL. Dental extraction has also been reported as triggering event. Case reports: Seven otherwise healthy patients are presented with severe and extensive RHL occurring about 2-3 days after dental extraction under local anaesthesia. Immunohistochemistry on smears and immunofluorescence on cell culture identified herpes simplex virus type I (HSV-I). Five patients reported more severe prodromal signs than usual. Although all the patients suffered from RHL, none had previously experienced RHL aft…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentmedicine.disease_causeSeverity of Illness IndexYoung AdultSeverity of illnessHumansMedicineYoung adultGeneral DentistryHerpes Labialisbusiness.industryIncidence (epidemiology)Herpes SimplexMiddle Aged:CIENCIAS MÉDICAS [UNESCO]DermatologySurgeryValaciclovirHerpes simplex virusOtorhinolaryngologyDental extractionTooth ExtractionUNESCO::CIENCIAS MÉDICASFemaleSurgerybusinessComplicationmedicine.drug
researchProduct

Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients

2018

Abstract Background The clinical response after comprehensive symptom management is difficult to determine in terms of a clinically important difference. Moreover, therapies should try to reach the threshold perceived by the individual patient for the determination of a favorable response to a treatment. Measures The Edmonton Symptom Assessment Score (ESAS) was measured at admission (T0), and seven days after starting palliative care (T7). Patient Global Impression and Goal Response after one week of palliative care and its relation with the Personalized Dyspnea Goal were measured at T7. Intervention Patients admitted to palliative care units underwent a comprehensive symptom assessment by …

AdultMalemedicine.medical_specialtypersonalized symptom goalPalliative careDecision MakingSymptom assessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicineNeoplasmsAdvanced cancerHumansMedicine030212 general & internal medicinePrecision MedicineGeneral NursingSpecialist palliative careglobal impression of changeNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and oversymptom assessmentpalliative carebusiness.industrySymptom managementMinimal clinically important differenceDisease ManagementMiddle AgeddyspneaAnticipation PsychologicalAdvanced cancerrespiratory tract diseasesIntensity (physics)Treatment OutcomeAnesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyDeliriumFemaleNeurology (clinical)medicine.symptombusiness
researchProduct

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia

2021

In β-thalassaemia, the severity of inherited β-globin gene mutations determines the severity of the clinical phenotype at presentation and subsequent transfusion requirements. However, data on associated long-term outcomes remain limited. We analysed data from 2109 β-thalassaemia patients with available genotypes in a global database. Genotype severity was grouped as β0 /β0 , β0 /β+ , β+ /β+ , β0 /β++ , β+ /β++ , and β++ /β++ . Patients were followed from birth until death or loss to follow-up. The median follow-up time was 34·1 years. Mortality and multiple morbidity outcomes were analyzed through five different stratification models of genotype severity groups. Interestingly, β0 and β+ mu…

AdultMalemedicine.medical_specialtyphenotypegenotypemorbidityKaplan-Meier Estimatebeta-GlobinsGene mutationβ thalassaemiaGlobal HealthGastroenterologySeverity of Illness IndexsurvivalCohort StudiesYoung AdultInternal medicineGenotypemedicineLong term outcomesOdds RatioHumansAllelesgenotype; morbidity; mortality; phenotype; survivalProportional Hazards Modelsbusiness.industrybeta-ThalassemiaDisease ManagementHematologyPrognosisPhenotypemortalityConfidence intervalPopulation SurveillanceCohortMutationFemaleRisk of deathbusinessFollow-Up Studies
researchProduct